Patents by Inventor Umberto Cornelli

Umberto Cornelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PREMENSTRUAL SYNDROME (PMS)
    Publication number: 20230119135
    Abstract: The present invention relates to a pharmaceutical composition comprising at least one Vitamin of the group D, lycopene, at least one flavonoid, at least one terpene and at least one calcium salt of a (C1-C3) carboxylic acid for use in the treatment of one or more menstrual disorders selected from the group consisting of Dysmenorrhea and Premenstrual syndrome (PMS).
    Type: Application
    Filed: February 23, 2021
    Publication date: April 20, 2023
    Inventor: Umberto Cornelli
  • Method for determining the antioxidant power of biological or vegetal fluids
    Patent number: 9442124
    Abstract: A method is described for determining the antioxidant power of biological fluids such as saliva, serum, plasma, urine, sweat, tears and vegetal fluids, such as fruit, vegetables, beverages derived therefrom. Said method proved to be particularly suitable when evaluating the antioxidant power of saliva, which presents particular complexities from the analytical viewpoint. Furthermore, the present invention concerns a specific reagent and a kit for implementing said method, which comprises said reagent.
    Type: Grant
    Filed: February 23, 2011
    Date of Patent: September 13, 2016
    Assignee: COR.CON INTERNATIONAL, S.R.L.
    Inventor: Umberto Cornelli
  • Bakery products and pasta capable to reduce body weight and plasma cholesterol, lipids and glucose
    Patent number: 9414616
    Abstract: The present invention relates to flour-based food products containing Nopal (Opuntia ficus-indica) capable to reduce body weight and plasma LDL cholesterol, lipids and glucose.
    Type: Grant
    Filed: May 13, 2009
    Date of Patent: August 16, 2016
    Assignee: COR. CON. INTERNATIONAL S.R.L.
    Inventor: Umberto Cornelli
  • Pharmaceutical compositions active in preventing, stabilizing and treating Alzheimer's disease
    Patent number: 9198967
    Abstract: The present invention relates to pharmaceutical compositions active in preventing, stabilizing and treating Alzheimer's disease and cognitive dysfunctions related thereto.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: December 1, 2015
    Inventor: Umberto Cornelli
  • Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome
    Patent number: 9050356
    Abstract: The present invention relates to compositions comprising chitosan, in the form of drugs or food supplements, suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome. Also described is their preparation. More generally, the invention concerns the use of chitosan for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome.
    Type: Grant
    Filed: March 2, 2007
    Date of Patent: June 9, 2015
    Assignee: Cor. Con. International S.R.L.
    Inventor: Umberto Cornelli
  • Bakery and pasta products comprising acidified chitosan
    Patent number: 8722127
    Abstract: Bakery products and pasta with added chitosan are disclosed. The chitosan is addified with a biologically acceptable acid and added to pasta and baked products. Once the baked products and/or pasta are ingested, gastro-intestinal absorption of fats is limited even after cooking.
    Type: Grant
    Filed: February 2, 2006
    Date of Patent: May 13, 2014
    Assignee: Cor. Con. International S.R.L.
    Inventor: Umberto Cornelli
  • Antioxidant Composition for Reducing Oxidative Stress Ascribable to the Treatment with Hormonal Contraceptive Drugs
    Publication number: 20130251696
    Abstract: An antioxidant composition is described for reducing oxidative stress in subjects undergoing hormonal contraceptive drug treatment. In particular, said composition has proved to be particularly suitable because, as well as being surprisingly effective, it is extremely well-tolerated by the body as it contains natural components such as catechins from green tea, selenium yeast, alpha-lipoic acid, and coenzyme Q10.
    Type: Application
    Filed: March 11, 2011
    Publication date: September 26, 2013
    Applicant: COR.CON. INTERNATIONAL S.R.L.
    Inventor: Umberto Cornelli
  • Method for Determining the Antioxidant Power of Biological Vegetal Fluids
    Publication number: 20120309102
    Abstract: A method is described for determining the antioxidant power of biological fluids such as saliva, serum, plasma, urine, sweat, tears and vegetal fluids, such as fruit, vegetables, beverages derived therefrom. Said method proved to be particularly suitable when evaluating the antioxidant power of saliva, which presents particular complexities from the analytical viewpoint. Furthermore, the present invention concerns a specific reagent and a kit for implementing said method, which comprises said reagent.
    Type: Application
    Filed: February 23, 2011
    Publication date: December 6, 2012
    Applicant: COR.CON. INTERNATIONAL S.R.L.
    Inventor: Umberto Cornelli
  • PHARMACEUTICAL COMPOSITIONS ACTIVE IN PREVENTING, STABILIZING AND TREATING ALZHEIMER'S DISEASE
    Publication number: 20120064054
    Abstract: The present invention relates to pharmaceutical compositions active in preventing, stabilizing and treating Alzheimer's disease and cognitive dysfunctions related thereto.
    Type: Application
    Filed: March 5, 2010
    Publication date: March 15, 2012
    Inventor: Umberto Cornelli
  • Glycosaminoglycans for treatment of emotional dysfunctions
    Patent number: 7812005
    Abstract: The present invention relates to the use of glycosaminoglycan fractions having an average molecular weight of 2400 (±200) D for the preparation of pharmaceutical compositions suitable for the treatment of emotional dysfunctions, especially depressive disorders, anxiety disorders, anxiety neurosis, agitation, confusion.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: October 12, 2010
    Inventors: Umberto Cornelli, Luigi De Ambrosi, Stanley Lorens, Jawed Fareed, John Lee, Israel Hanin, Ronald Mervis
  • BAKERY AND PASTA PRODUCTS COMPRISING ACIDIFIED CHITOSAN
    Publication number: 20100034947
    Abstract: The present invention relates to bakery products and pasta with added acidified chitosan.
    Type: Application
    Filed: February 2, 2006
    Publication date: February 11, 2010
    Inventor: Umberto Cornelli
  • BAKERY PRODUCTS AND PASTA CAPABLE TO REDUCE BODY WEIGHT AND PLASMA CHOLESTEROL, LIPIDS AND GLUCOSE
    Publication number: 20090285922
    Abstract: The present invention relates to flour-based food products containing Nopal (Opuntia ficus-indica) capable to reduce body weight and plasma LDL cholesterol, lipids and glucose.
    Type: Application
    Filed: May 13, 2009
    Publication date: November 19, 2009
    Inventor: Umberto Cornelli
  • COMPOSITIONS COMPRISING CHITOSAN SUITABLE FOR COMPREHENSIVE THERAPEUTIC TREATMENT OR COMPREHENSIVE PREVENTION OF THE METABOLIC SYNDROME
    Publication number: 20090258839
    Abstract: The present invention relates to compositions comprising chitosan, in the form of drugs or food supplements, suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome. Also described is their preparation. More generally, the invention concerns the use of chitosan for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome.
    Type: Application
    Filed: March 2, 2007
    Publication date: October 15, 2009
    Inventor: Umberto Cornelli
  • Glycosaminoglycans for treatment of emotional dysfunctions
    Publication number: 20060205690
    Abstract: The present invention relates to the use of glycosaminoglycan fractions having an average molecular weight of 2400 (?200) D for the preparation of pharmaceutical compositions suitable for the treatment of emotional dysfunctions, especially depressive disorders, anxiety disorders, anxiety neurosis, agitation, confusion.
    Type: Application
    Filed: May 19, 2004
    Publication date: September 14, 2006
    Inventors: Umberto Cornelli, Luigi Ambrosi, Stanley Lorens, Jawed Fareed, John Lee, Israel Hanin, Ronald Mervis
  • Glycosaminoglycans having an average molecular weight of 2400 D suitable for the treatment of senile dementia
    Patent number: 6979680
    Abstract: The present invention relates to the use of glycosaminoglycans having an average/molecular weight of 2,400 D for the preparation of pharmaceutical compositions suitable for the treatment of senile dementia, in particular for the treatment of Alzheimer's disease or SDAT (Senile Dementia Alzheimer's Type) and of the cerebral neurological lesions from ictus and from traumas.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: December 27, 2005
    Inventors: Umberto Cornelli, Luigi De Ambrosi, Israel Hanin, Jawed Fareed, John Lee, Stanley Lorens, Ronald F. Mervis
  • Use of sulfomucopolysaccharides in the treatment of Alzheimer-type senile dementia
    Patent number: 4956347
    Abstract: The administration of ateroid alleviates the symptoms of Alzheimer-type senile dementia.
    Type: Grant
    Filed: May 23, 1988
    Date of Patent: September 11, 1990
    Assignee: Crinos industria Farmacobiologica SpA
    Inventors: Thomas A. Ban, Umberto Cornelli